Section 9.1: Texas Generic Substitution Law

Section 9.1: Texas Generic Substitution Law

Texas pharmacy law regarding generic drug and biological product substitution is designed to provide patients with access to lower-cost, therapeutically equivalent medications. These provisions are codified under the Texas Pharmacy Act (Texas Occupations Code Chapter 562, Subchapter A) and Texas State Board of Pharmacy (TSBP) Rules (22 TAC Chapter 309). Understanding the precise legal requirements for substitution, the methods by which a prescriber can prohibit it, and the professional responsibilities of the dispensing pharmacist is critical for the Texas MPJE.

Core Substitution Requirements

Under Texas law, a pharmacist is authorized and generally expected to substitute a generically equivalent drug or interchangeable biological product if three core conditions are met:

1. Cost Savings: The substituted drug or biological product must be less expensive than the brand-name product prescribed. It is illegal to substitute a generic drug that costs more than the prescribed brand-name drug.
2. Patient Consent: The patient (or the patient’s agent) does not refuse the substitution. If the patient insists on the brand-name drug, the pharmacist must dispense the brand, even if substitution is permitted by the prescriber.
3. Prescriber Authorization: The practitioner has not prohibited substitution in accordance with Texas law.

If any of these conditions are not met, the brand-name drug must be dispensed.

Prohibiting Substitution: The "Brand Necessary" Rule

The legal requirements for a practitioner to prohibit generic substitution vary depending on how the prescription is transmitted to the pharmacy. In Texas, the standards are exceptionally strict, especially for written prescriptions, to prevent preprinted or automated defaults from overriding patient choice.

1. Written Prescriptions

For a written prescription, the practitioner must write the phrase "brand necessary" or "brand medically necessary" in their own handwriting on the face of the prescription.

• Invalid Methods: Preprinted check boxes, dual signature lines (e.g., "Dispense as Written" vs. "Substitution Permitted"), rubber stamps, electronic defaults printed on paper, or initials next to a preprinted statement are legally invalid in Texas. If a prescriber checks a box or uses a stamp, the pharmacist is legally authorized—and required—to substitute, unless the patient objects.
• Out-of-State Prescriptions: If a written prescription is received from an out-of-state prescriber (or a licensed practitioner in Canada or Mexico), the Texas generic substitution rules still apply. If the out-of-state prescription has a preprinted box checked or a stamp prohibiting substitution, it does not comply with Texas's handwritten requirement, and the pharmacist may legally substitute a generically equivalent drug.

2. Electronic Prescriptions

For an electronic prescription, the prescriber must specifically select or transmit the instruction to prevent substitution (e.g., checking a secure box in the e-prescribing software that transmits the "brand necessary" flag). The electronic transmission must contain the prohibition; it cannot be a default system setting that cannot be overridden by the prescriber.

3. Oral (Telephoned) Prescriptions

For an oral prescription, the prescriber must verbally state "brand necessary" or "brand medically necessary" during the phone call. The pharmacist (or intern/technician taking the call) must document this instruction immediately on the written memo of the oral prescription.

Determining Equivalency: The Orange and Purple Books

A pharmacist cannot substitute just any drug that seems similar. They must rely on established scientific resources to verify therapeutic equivalence.

1. Small-Molecule Generic Drugs (The Orange Book)

Pharmacists must use the FDA's Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book.

• A-Rated Drugs: Only drug products designated with an "A" rating (e.g., AA, AB, AN, AO, AP, AT) are considered therapeutically equivalent and may be substituted. AB-rated products have resolved bioequivalence issues and are the most common subjects of substitution.
• B-Rated Drugs: Drug products with a "B" rating (e.g., BC, BD, BX) are NOT considered therapeutically equivalent and cannot be substituted under Texas law. Dispensing a B-rated generic in place of a brand drug is considered a dispensing error and a violation of the Texas Pharmacy Act.

2. Biological Products (The Purple Book)

For biological products, pharmacists must consult the FDA's Lists of Licensed Biological Products with Reference Product Exclusivity and Biosimilarity or Interchangeability Evaluations, commonly known as the Purple Book.

• Interchangeable Biologicals: A pharmacist may only substitute a biological product if the FDA has determined it to be "interchangeable" with the reference product.
• Biosimilars: A standard "biosimilar" product is not considered interchangeable. Substitution of a biosimilar without prescriber intervention is prohibited. The product must specifically carry the "interchangeable" designation in the Purple Book.

Notification Requirements and Sibling Rules

When a pharmacist substitutes a medication, certain notification requirements must be met to ensure transparency.

1. Patient Notification

The pharmacist must inform the patient, either verbally or in writing, that a less expensive generically equivalent drug or interchangeable biological product has been substituted. This notification typically occurs at the point of sale.

2. Practitioner Notification for Biologicals (The 3-Business-Day Rule)

For generic small-molecule drugs, the pharmacist does not need to notify the prescriber. However, for biological products, Texas law imposes a strict 3-business-day post-dispensing notification rule:

• Within 3 business days of dispensing an interchangeable biological product, the pharmacist (or pharmacy staff) must communicate the specific product name and manufacturer to the prescribing practitioner.
• This communication can be completed by entering the dispensing detail into an interoperable electronic medical records (EMR) system, prescribing software, a shared pharmacy network, or the state's Prescription Monitoring Program (PMP).
• If an electronic system is not available, the pharmacist must notify the practitioner via telephone, fax, or email.
• Exception: Notification is not required if there is no interchangeable product for the prescribed biological, or if the prescription is a refill and the product dispensed is identical to the one dispensed at the prior fill.

3. Pharmacy Signage Requirement

Every pharmacy in Texas must display a sign in both English and Spanish in a prominent place near the prescription department. The sign must state:

"Texas law requires a pharmacist to offer a less expensive generically equivalent drug or interchangeable biological product if one is available, unless your physician requires the brand name drug by writing 'brand necessary' on the prescription."

Common Exam Traps and Legal Nuances

• Medicaid Patients: For patients covered by Texas Medicaid, the program may require generic substitution as a condition of reimbursement. However, if the prescriber handwrites "brand medically necessary" and obtains prior authorization if required, the brand-name drug can be dispensed.
• Narrow Therapeutic Index (NTI) Drugs: Texas does not have a separate, restrictive NTI drug substitution list (unlike some other states). However, TSBP rules require pharmacists to exercise caution, and practitioners often enforce brand-name dispensing for NTI drugs like warfarin, digoxin, or levothyroxine by handwriting "brand necessary".
• Preprinted Boxes on Out-of-State Prescriptions: Always remember that Texas pharmacy laws govern the dispensing of prescriptions within Texas. An out-of-state prescription filled in a Texas pharmacy must comply with Texas generic substitution rules. Since a checked preprinted box is invalid in Texas, a Texas pharmacist can legally substitute a generic for a written out-of-state prescription containing only a checked box.